(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-1.01%) $83.00
(-1.16%) $1.619
(-0.41%) $2 337.50
(-0.49%) $27.40
(0.52%) $926.90
(-0.13%) $0.933
(-0.11%) $11.01
(-0.21%) $0.799
(0.00%) $92.17
Quarter results tomorrow
(bmo 2024-04-30)
Expected move: +/- 4.51%
8.44% £ 48.80
Live Chart Being Loaded With Signals
Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe...
Stats | |
---|---|
Dzisiejszy wolumen | 5.64M |
Średni wolumen | 3.20M |
Kapitalizacja rynkowa | 159.86M |
EPS | £0 ( 2024-04-22 ) |
Następna data zysków | ( £0 ) 2024-04-30 |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -3.05 |
ATR14 | £0.191 (0.39%) |
Wolumen Korelacja
Avacta Group PLC Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
TEM.L | 0.92 |
JAGI.L | 0.92 |
XMMS.L | 0.893 |
FCSS.L | 0.889 |
HSXJ.L | 0.885 |
EMIM.L | 0.885 |
JMG.L | 0.883 |
FEMS.L | 0.88 |
AEMD.L | 0.876 |
LAND.L | 0.875 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Avacta Group PLC Korelacja - Waluta/Towar
Avacta Group PLC Finanse
Annual | 2022 |
Przychody: | £9.65M |
Zysk brutto: | £4.23M (43.83 %) |
EPS: | £-0.150 |
FY | 2022 |
Przychody: | £9.65M |
Zysk brutto: | £4.23M (43.83 %) |
EPS: | £-0.150 |
FY | 2021 |
Przychody: | £2.94M |
Zysk brutto: | £2.02M (68.58 %) |
EPS: | £-0.106 |
FY | 2020 |
Przychody: | £3.64M |
Zysk brutto: | £2.18M (59.98 %) |
EPS: | £-0.0837 |
Financial Reports:
No articles found.
Avacta Group PLC
Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays. It also develops AffiDX SARS-CoV-2 lateral flow rapid antigen tests, as well as Affimer reagents for third party products; and novel cancer immunotherapies combining proprietary platforms. The company has a research collaboration with pre|CISION technology incorporates a substrate that is sensitive to cleavage by fibroblast activation protein alpha; drug development collaboration with LG Chem Life Sciences; partnership with Tufts University School of Medicine for developing Affimer drug conjugate therapies; licensing agreement with POINT Biopharma Inc. for the development of tumour activated radiopharmaceuticals; and drug development partnership with AffyXell to develop engineered mesenchymal stem cells to treat autoimmune diseases. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej